World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

OVARIAN SERTOLI-LEYDIG CELL TUMOR: A CASE REPORT

F. Amqrane*, Z. Bennani, M. Krioul, H. Souradi, S. Bargach and M. Youssfi

ABSTRACT

We present the case of a 20-year-old woman, without any particular pathological history, who consulted for a secondary amenorrhea of 6 months and in whom the clinical examination found an abdominal-pelvic mass, The biological workup, in particular hormonal, and the chest X-ray were without abnormalities. Macroscopically, the tumor had a cystic component with necrotic fibrosis. Anatomopathological examination confirmed the diagnosis of Sertoli-Leydig tumor. The diagnosis of Sertoli-Leydig tumor was made. It is a rare tumor, representing less than 0.5% of all ovarian tumors. Well-differentiated forms are uncommon. In one third of cases, they are clinically expressed by hypervirilization, and imaging will be used to orient the diagnosis and especially to make the extension assessment. There are several histological subforms. The management is not codified, each center having its own practices. This is a tumour with a relatively good prognosis due to its early diagnosis with a lesion still limited to the ovary.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR